Pulmicort

Budesonide 200mcg
(Brand) Astra
1 200 doses
inhalar
74 € Buy Now

Singulair

asthma
Montelukast sodium 5mg
(Brand) MSD
28 Tablets 82 € Buy Now
Montelukast sodium 10mg
(Brand) MSD
28 Tablets 87 € Buy Now

Foradil

Foranoterol fumerate
12mcg/cap (Brand) Novartis
60 Caps Inhalation-caps 78 € Buy Now

Serevent

Salmetrol 25mcg/dose
(Brand) GSK
1 200 doses
inhalar
65 € Buy Now
Salmetrol diskus
50mcg/dose (Brand) GSK
60 Inhalation
caps
69 € Buy Now

Seretide

50/250 (Brand) GSK 1 Inhalar 78 € Buy Now
50/500 (Brand) GSK 1 Inhalar 87 € Buy Now

Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and COPD.

Formoterol has an extended duration of action (up to 12 h)

compared to short-acting β2 agonists such as salbutamol (albuterol),

which are effective for 4 h to 6 h. LABAs such as formoterol are used as “symptom controllers” to supplement

prophylactic corticosteroid therapy.

A “reliever” short-acting β2 agonist (e.g., salbutamol) is still required since LABAs are not recommended for the

treatment of acute asthma

n November 2005, the US FDA released a health advisory alerting the public to findings that show the use of long-

acting β2 agonists could lead to a worsening of wheezing symptoms in some patients.[2]

At the current time, available long-acting β2 agonists include salmeterol, formoterol, bambuterol,

and sustained-release oral salbutamol.

Combinations of inhaled steroids and long-acting bronchodilators are becoming more widespread – combination

preparations include fluticasone/salmeterol and budesonide/formoterol